Skip to main content

Research Repository

Advanced Search

TR12: A Phase 2, Double-blind, Randomized, Placebo-controlled, Two-Treatment, Two-Period Crossover Efficacy and Safety Study in Idiopathic Pulmonary Fibrosis with Nalbuphine ER Tablets for the Treatment of Cough

People Involved

Project Acronym TR12
Status Project Complete
Value £20,357.00
Project Dates Oct 1, 2019 - Dec 31, 2022

You might also like